Details
Category: Volume 07 Issue 12 December 2019
Hits: 1059

Title: Extended and Pan-drug resistance in Klebsiella pneumoniae due to Carbapenemase and Extended Spectrum b-lactamase enzymes

Authors: Lokhande Suman R., Pawar Sunil T., Karad Dilip. D.

 DOI: https://dx.doi.org/10.18535/jmscr/v7i12.91

Abstract

Purpose: Emergence of resistance to multiple antimicrobial agents in pathogenic bacteria has become a significant public health threat as there are fewer, or even sometimes no effective antimicrobial agents available for infections caused by these bacterial pathogens. Infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKP) and Extended Spectrum b-lactamase (ESBL) enzyme is a worldwide problem associated with high rates of treatment failure and mortality. Objective of the present investigation is to study molecular characterization of K. pneumoniae resistant due to ESBL and carbapenemase enzymes and other mechanism of antibiotic resistant.

Methods: Three hundred and eleven K. pneumoniae cultures were isolated and identified from clinical samples from hospitals in Barshi-Solapur, Maharashtra, India. Antibiotic susceptibility was determined by manually as well as by Vitek-2 machine. The enzymatic β-lactam resistance mechanism was confirmed through specific β-lactamase gene PCR genotype determination.

Results: ESBL resistance was observed in 310 (88.57%) isolates and carbapenemase in 181 (51.71%) isolates were the main mechanism of antibiotic resistance. We found 29 (8.28%) isolates K. pneumoniae pan-drug resistant meaning resistant to all antibiotics and 52 (14.85%) isolates susceptible to colistin only. We found extreme drug resistance in 135 (38.57%) of the K. pneumoniae isolates. Majority of K. pneumoniae isolated were resistant to all antimicrobial agents denoting prevalence of high antibiotic resistance.

Conclusion: Carbapenemase and Extended Spectrum b-lactamase enzymes are responsible for extended and pan-drug resistance in K. pneumoniae isolated from clinical samples. PCR assay for genes in six isolates were detected and responsible for the drug resistance.

Keywords: Klebsiella pneumoniae, Vitek-2, Drug resistance, ESBL, Carbapenemase.

References

  1. Nordmann P. Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge. Med Mal Infect 2014; 44:51-56. PMID: 24360201
  2. Stefanuk E, Mrowka A, Hryniewicz W. Susceptibility testing and resistance phenotypes detection in bacterial pathogens using the VITEK 2 System. Pol J. Microbiol 2005; 54 (4):311-6. PMID: 16599303
  3. Odsbu I, Khedkar S, Lind F, Khedkar U, Nerkar SS, Orsini N et al. Trends in Resistance to Extended-Spectrum Cephalosporins and Carbapenems among Escherichia coli and Klebsiella spp. Isolates in a District in Western India during 2004-2014. Int J Environ Res Public Health. 2018 19;15(1). pii: E155. PMID: 29351236
  4. Livermore DM, Struelens M, Amorim J, Baquero F, Bille J, Canton R, et al. Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests. J Antimicrob Chemother. 2002, 49(2),289-300. PMID: 11815570
  5. Performance Standards for Antimicrobial Disk Susceptibility Tests. 13th ed. CLSI standard M02. Clinical and Laboratory Standards Institute 2018.
  6. Mlynarcik Patrik, Roderova M, Kolar M. Primer Evaluation for PCR and its Application for Detection of Carbapenemases in Enterobacteriaceae. Jundishapur J. Microbiol. 2016 Jan 2;9(1):e29314. PMID: 27099689
  7. Savitha Rani, Jahnavi I, Nagamani K. Phenotypic and Molecular Characterization of ESBLs producing Enterobacteriaceae in A Tertiary Care Hospital Journal of Dental and Medical Sciences. 2016; 15 (8): Ver. IX: PP 27 – 34 DOI: 10.9790/0853-1508092734
  8. Dallenne C, Da Costa A, Decre D, Favier C, Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J. Antimicrob. Chemother. 2010 Mar; 65 (3):490-5. PMID: 20071363
  9. Tehrani KHME, Martin NI. β-lactam/β-lactamase inhibitor combinations: an update. Medchemcomm. 2018. 17; 9(9):1439-1456. PMID: 30288219
  1. Shoja S, Ansari M, Faridi F, Azad M, Davoodian P, Javadpour S, et al., Identification of Carbapenem-Resistant Klebsiella pneumoniae with Emphasis on New Delhi Metallo-Beta-Lactamase-1 (blaNDM-1) in Bandar Abbas, South of Iran. Microb Drug Resist. 2018; 24(4): 447-454. PMID: 28972857 DOI: 10.1089/mdr.2017.0058
  2. Shakib P, Ramazanzadeh R, Taherikalani M, Nouri B. Detection of Extended-Spectrum Beta-Lactamases (ESBLs) and Antibiotic Susceptibility Patterns in Klebsiella pneumoniae in Western Iran. Infect Disord Drug Targets. 2018;18(2):156-163. PMID: 28707597
  3. Cuzon G, Naas T, Truong H, Villegas MV, Wisell KT, Carmeli Y. et al. Worldwide diversity of Klebsiella pneumoniae that produce ß-lactamase blaKPC-2 gene. Emerg Infect Dis 2010; 16:1349-1356. PMID: 20735917
  4. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Balakrishnan R. et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010; 10(9):597-602. PMID: 20705517
  5. Dortet L, Poirel L, Nordmann P. Worldwide dissemination of the NDM-type carbapenemses in Gram-negative bacteria. Biomed Res Int. 2014:249856. PMID: 24790993
  6. Johnson AP, Woodford N. Global spread of antibiotic resistance; the example of New Delhi metallo-ß-lactamase (NDM)- mediated carbapenem resistance type. J Med Microbiol 2013; 62: 499-513. PMID: 23329317
  7. Berrazeg M, Diene S, Medjahed L, Parola P, Drissi M., Raoult D, Rolain J. New Delhi Metallo-beta-lactamase around the world: an eReview using Google Maps.Euro Surveill. 2014;19 (20): pii: 20809. PMID: 24871756
  8. Groundwater PW, Xu S, Lai F, Varadi L, Tan J, Perry JD, Hibbs DE. New Delhi metallo-β-lactamase-1: structure, inhibitors and detection of producers. Future Med Chem. 2016 Jun; 8(9):993-1012. PMID: 27253479
  9. Linciano P, Cendron L, Gianquinto E, Spyrakis F, Tondi D. Ten Years with New Delhi Metallo-β-lactamase-1 (NDM-1): From Structural Insights to Inhibitor Design. ACS Infect Dis. 2018; PMID: 30421910
  10. Mitgang EA, Hartley DM, Malchione MD, Koch M, Goodman JL, Review and mapping of carbapenem-resistant Enterobacteriaceae in Africa: Using diverse data to inform surveillance gaps. Int J Antimicrob Agents. 2018; 52 (3):372-384. PMID: 29864500
  11. Aguirre-Quinonero A, Martinez-Martinez L. Non-molecular detection of carbapenemases in Enterobacteriaceae clinical isolates. J Infect Chemother 2017, 23(1): 1-11.

Corresponding Author

Prof. Sunil T Pawar

Department of Microbiology, Tuljaram Chaturchand College of Arts, Science & Commerce, Baramati – 413102, India